Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation
- PMID: 18550063
- DOI: 10.1016/j.atherosclerosis.2008.03.024
Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation
Abstract
Objective: Inflammatory stimuli profoundly increase the vulnerability of the vessel wall to atherogenesis. The endothelial glycocalyx, a layer of glycosaminoglycans and proteoglycans covering the luminal side of the vasculature, has recently emerged as an orchestrator of vascular homeostasis. In the present study, we investigated whether endotoxin-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether tumor necrosis factor-alpha (TNFalpha) plays a role in this process.
Design, subjects and intervention: Healthy male volunteers received low-dose endotoxin (1ng/kg) intravenously, with (n=8) or without (n=13) pre-treatment with the soluble TNFalpha receptor etanercept. Endothelial glycocalyx thickness and related parameters were determined after endotoxin challenge.
Results: Endotoxin resulted in a profound reduction in microvascular glycocalyx thickness (from 0.60+/-0.1 to 0.30+/-0.1microm, p<0.01). Concomitantly, plasma levels of the principal glycocalyx constituent hyaluronan (62+/-18 to 85+/-24ng/mL, p<0.05), monocyte activation and coagulation activation increased (F1+2; 0.3+/-0.1 to 2.8+/-1.5nmol/L, p<0.05 and d-dimer; from 0.2+/-0.1 to 0.4+/-0.1mg/L, p<0.05 compared to baseline). Inhibition of TNFalpha by etanercept attenuated loss of microvascular glycocalyx thickness (0.54+/-0.1 to 0.35+/-0.1mum, p<0.05). Changes in hyaluronan (58+/-13 to 46+/-10ng/mL, p<0.05) and coagulation activation were also attenuated (F1+2; 0.3+/-0.1 to 2.1+/-0.9nmol/L and d-dimer; from 0.2+/-0.1 to 0.3+/-0.1mg/L, p<0.05 compared to baseline).
Conclusions: These data suggest that inflammatory activity, in part mediated by TNFalpha, leads to perturbation of the endothelial glycocalyx in humans. This may contribute to the vascular vulnerability induced by inflammation.
Similar articles
-
Damage of the endothelial glycocalyx in chronic kidney disease.Atherosclerosis. 2014 Jun;234(2):335-43. doi: 10.1016/j.atherosclerosis.2014.03.016. Epub 2014 Mar 29. Atherosclerosis. 2014. PMID: 24727235
-
The tumor necrosis factor alpha -308 G/A polymorphism does not influence inflammation and coagulation response in human endotoxemia.Shock. 2007 Mar;27(3):238-41. doi: 10.1097/01.shk.0000239768.64786.3a. Shock. 2007. PMID: 17304103
-
Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans.Thromb Haemost. 1998 Jul;80(1):114-8. Thromb Haemost. 1998. PMID: 9684796 Clinical Trial.
-
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects.Int Angiol. 2014 Jun;33(3):243-54. Int Angiol. 2014. PMID: 24936533 Review.
-
Glycocalyx and endothelial (dys) function: from mice to men.Pharmacol Rep. 2006;58 Suppl:75-80. Pharmacol Rep. 2006. PMID: 17332675 Review.
Cited by
-
Managing sepsis and septic shock in an endothelial glycocalyx-friendly way: from the viewpoint of surviving sepsis campaign guidelines.Ann Intensive Care. 2024 Apr 24;14(1):64. doi: 10.1186/s13613-024-01301-6. Ann Intensive Care. 2024. PMID: 38658435 Free PMC article. Review.
-
Endothelial Glycocalyx of Peritubular Capillaries in Experimental Diabetic Nephropathy: A Target of ACE Inhibitor-Induced Kidney Microvascular Protection.Int J Mol Sci. 2023 Nov 20;24(22):16543. doi: 10.3390/ijms242216543. Int J Mol Sci. 2023. PMID: 38003732 Free PMC article.
-
Fluid restrictive resuscitation with high molecular weight hyaluronan infusion in early peritonitis sepsis.Intensive Care Med Exp. 2023 Sep 21;11(1):63. doi: 10.1186/s40635-023-00548-w. Intensive Care Med Exp. 2023. PMID: 37733256 Free PMC article.
-
Early diabetic kidney disease: Focus on the glycocalyx.World J Diabetes. 2023 May 15;14(5):460-480. doi: 10.4239/wjd.v14.i5.460. World J Diabetes. 2023. PMID: 37273258 Free PMC article. Review.
-
Endothelial Dysfunction in Patients Undergoing Cardiac Surgery: A Narrative Review and Clinical Implications.J Cardiovasc Dev Dis. 2023 May 13;10(5):213. doi: 10.3390/jcdd10050213. J Cardiovasc Dev Dis. 2023. PMID: 37233179 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources